Cargando…

Ferroptosis in cancer therapy: a novel approach to reversing drug resistance

Ferroptosis is an intracellular iron-dependent form of cell death that is distinct from apoptosis, necrosis, and autophagy. Extensive studies suggest that ferroptosis plays a pivotal role in tumor suppression, thus providing new opportunities for cancer therapy. The development of resistance to canc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Chen, Liu, Xinyin, Jin, Shidai, Chen, Yi, Guo, Renhua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8840702/ https://www.ncbi.nlm.nih.gov/pubmed/35151318 http://dx.doi.org/10.1186/s12943-022-01530-y

Ejemplares similares

Carbonic Anhydrase IX Controls Vulnerability to Ferroptosis in Gefitinib-Resistant Lung Cancer
por: Zhang, Chen, et al.
Publicado: (2023)

Efficacy and safety of antiangiogenic agents or chemotherapy plus EGFR‐TKIs in advanced non‐small cell lung cancer: A systematic review and network meta‐analysis
por: Dai, Jiali, et al.
Publicado: (2023)

Pemetrexed induces ROS generation and cellular senescence by attenuating TS‐mediated thymidylate metabolism to reverse gefitinib resistance in NSCLC
por: Chen, Yun, et al.
Publicado: (2023)

LINC00665 Induces Acquired Resistance to Gefitinib through Recruiting EZH2 and Activating PI3K/AKT Pathway in NSCLC
por: Liu, Xinyin, et al.
Publicado: (2019)

Harnessing Ferroptosis to Overcome Drug Resistance in Colorectal Cancer: Promising Therapeutic Approaches
por: Cheng, Xiaofei, et al.
Publicado: (2023)

MiR‐873 inhibition enhances gefitinib resistance in non‐small cell lung cancer cells by targeting glioma‐associated oncogene homolog 1
por: Jin, Shidai, et al.
Publicado: (2018)

Concurrent use of anlotinib overcomes acquired resistance to EGFR‐TKI in patients with advanced EGFR‐mutant non‐small cell lung cancer
por: Zhang, Chen, et al.
Publicado: (2021)

Targeting Cancer Cell Ferroptosis to Reverse Immune Checkpoint Inhibitor Therapy Resistance
por: Deng, Jingjing, et al.
Publicado: (2022)

IL-22 Confers EGFR-TKI Resistance in NSCLC via the AKT and ERK Signaling Pathways
por: Wang, Xiaomeng, et al.
Publicado: (2019)

Novel insights on targeting ferroptosis in cancer therapy
por: Zuo, Sipeng, et al.
Publicado: (2020)

Ferroptosis and EMT: key targets for combating cancer progression and therapy resistance
por: Ren, Yuqing, et al.
Publicado: (2023)

Ferroptosis in lung cancer: a novel pathway regulating cell death and a promising target for drug therapy
por: Xing, Nan, et al.
Publicado: (2023)

Unleashing Ferroptosis in Human Cancers: Targeting Ferroptosis Suppressor Protein 1 for Overcoming Therapy Resistance
por: Lee, Jaewang, et al.
Publicado: (2023)

Ferroptosis: challenges and opportunities for nanomaterials in cancer therapy
por: Liu, Qiaolin, et al.
Publicado: (2023)

Mitochondrial Regulation of Ferroptosis in Cancer Therapy
por: Cheng, Xiaoxia, et al.
Publicado: (2023)

Ferroptosis: At the Crossroad of Gemcitabine Resistance and Tumorigenesis in Pancreatic Cancer
por: Yang, Jianhui, et al.
Publicado: (2021)

The development and validation of a nomogram for predicting brain metastases in lung squamous cell carcinoma patients: an analysis of the Surveillance, Epidemiology, and End Results (SEER) database
por: Zhang, Jingya, et al.
Publicado: (2021)

Deleterious AHNAK2 Mutation as a Novel Biomarker for Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer
por: Cui, Yanan, et al.
Publicado: (2022)

The reversal of antineoplastic drug resistance in cancer cells by β-elemene
por: Zhang, Guan-Nan, et al.
Publicado: (2015)

Drug-Resistant Stem Cells: Novel Approach for Colon Cancer Therapy
por: Telang, Nitin
Publicado: (2022)

Efficacy and acquired resistance of EGFR-TKI combined with chemotherapy as first-line treatment for Chinese patients with advanced non-small cell lung cancer in a real-world setting
por: Wang, Qianqian, et al.
Publicado: (2021)

Metabolic reprogramming, autophagy, and ferroptosis: Novel arsenals to overcome immunotherapy resistance in gastrointestinal cancer
por: Wang, Xiangwen, et al.
Publicado: (2023)

The crosstalk between autophagy and ferroptosis: what can we learn to target drug resistance in cancer?
por: Zhou, Yulu, et al.
Publicado: (2019)

Nanoparticles for Ferroptosis Therapy in Cancer
por: Zaffaroni, Nadia, et al.
Publicado: (2021)

Reversing ferroptosis resistance by MOFs through regulation intracellular redox homeostasis
por: Wang, Chengcheng, et al.
Publicado: (2023)

Targeting Iron Metabolism and Ferroptosis as Novel Therapeutic Approaches in Cardiovascular Diseases
por: Chen, Yufei, et al.
Publicado: (2023)

Insights Into Ferroptosis, a Novel Target for the Therapy of Cancer
por: Wang, Hong-Tao, et al.
Publicado: (2022)

Ferroptosis and Its Multifaceted Role in Cancer: Mechanisms and Therapeutic Approach
por: Chen, Heshu, et al.
Publicado: (2022)

Potential mechanism of ferroptosis in pancreatic cancer
por: Chen, Gang, et al.
Publicado: (2020)

Ferroptosis as a potential target for cancer therapy
por: Chen, Zhen, et al.
Publicado: (2023)

Ferroptosis, Necroptosis, and Pyroptosis in Gastrointestinal Cancers: The Chief Culprits of Tumor Progression and Drug Resistance
por: Zhu, Xudong, et al.
Publicado: (2023)

Induction and application of ferroptosis in cancer therapy
por: Nie, Qing, et al.
Publicado: (2022)

Subsequent chemotherapy reverses acquired tyrosine kinase inhibitor resistance and restores response to tyrosine kinase inhibitor in advanced non-small-cell lung cancer
por: Guo, Renhua, et al.
Publicado: (2011)

Inhibiting Ferroptosis: A Novel Approach for Ulcerative Colitis Therapeutics
por: Huang, Jinke, et al.
Publicado: (2022)

Ferroptosis and Tumor Drug Resistance: Current Status and Major Challenges
por: Nie, Zhenyu, et al.
Publicado: (2022)

A multicenter real-world study of tumor-derived DNA from pleural effusion supernatant in genomic profiling of advanced lung cancer
por: Jin, Shidai, et al.
Publicado: (2020)

Nanocarrier drug resistant tumor interactions: novel approaches to fight drug resistance in cancer
por: Benko, Aleksandra, et al.
Publicado: (2021)

Targeting critical pathways in ferroptosis and enhancing antitumor therapy of Platinum drugs for colorectal cancer
por: Wang, Gang, et al.
Publicado: (2023)

Charge-reversal nanoparticles: novel targeted drug delivery carriers
por: Chen, Xinli, et al.
Publicado: (2016)

Ferroptosis in Hepatocellular Carcinoma: Mechanisms, Drug Targets and Approaches to Clinical Translation
por: Bekric, Dino, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_u0k1j374ela03169q6g4rp23h8